As of close of business last night, MoonLake Immunotherapeutics’s stock clocked out at $52.12, up 0.13% from its previous closing price of $52.05. In other words, the price has increased by $+0.07 from its previous closing price. On the day, 619965 shares were traded. MLTX stock price reached its highest trading level at $53.40 during the session, while it also had its lowest trading level at $50.65.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
To gain a deeper understanding of MLTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 48.51 and its Current Ratio is at 48.51. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $77.
On December 08, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $72.
On November 02, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $74.Stifel initiated its Buy rating on November 02, 2023, with a $74 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 21 when Santos da Silva Jorge sold 1,125 shares for $55.27 per share. The transaction valued at 62,179 led to the insider holds 3,106,429 shares of the business.
Reich Kristian sold 569 shares of MLTX for $31,466 on Feb 21. The Chief Scientific Officer now owns 99,502 shares after completing the transaction at $55.30 per share. On Feb 21, another insider, Reich Kristian, who serves as the Chief Scientific Officer of the company, sold 509 shares for $55.31 each. As a result, the insider received 28,153 and left with 2,986,974 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MLTX now has a Market Capitalization of 3.12B and an Enterprise Value of 2.63B.
Stock Price History:
Over the past 52 weeks, MLTX has reached a high of $64.98, while it has fallen to a 52-week low of $17.32. The 50-Day Moving Average of the stock is 58.01, while the 200-Day Moving Average is calculated to be 49.90.
Shares Statistics:
It appears that MLTX traded 484.55K shares on average per day over the past three months and 419.98k shares per day over the past ten days. A total of 59.94M shares are outstanding, with a floating share count of 46.95M. Insiders hold about 21.68% of the company’s shares, while institutions hold 98.22% stake in the company. Shares short for MLTX as of Jan 31, 2024 were 6.67M with a Short Ratio of 13.76, compared to 6.91M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 11.12% and a Short% of Float of 21.30%.
Earnings Estimates
As of right now, 13 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.37, while EPS last year was -$0.31. The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.15 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$0.8 and -$1.19 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$1.28, with 12 analysts recommending between -$0.68 and -$2.12.
